{"entity":{"type":"insider","cik":"0001395064","url":"/insider/0001395064","json_url":"/insider/0001395064.json","name":"TAKEDA PHARMACEUTICAL CO LTD","name_source":"as-filed","also_issuer":true,"cross_url":"/issuer/0001395064"},"coverage_statement":{"n_transactions":65,"n_filings":29,"first":"2018-03-21","last":"2024-01-25","span_basis":"filed_date"},"name_variants":[{"name":"TAKEDA PHARMACEUTICAL CO LTD","source":"filing","n_filings":29,"first_seen":"2018-03-21","last_seen":"2024-01-25"}],"transactions":[{"id":3221744,"accession":"0001395064-24-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-24-000008","line_url":"/filing/0001395064-24-000008#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3703703.0,"shares_display":"3,703,703","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":29999994.3,"total_display":"29,999,994.30","total_whole":"29,999,994","shares_owned_after":3755583.0,"shares_owned_after_display":"3,755,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-25","scope":"insider"},{"id":6641367,"accession":"0001395064-22-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-22-000040","line_url":"/filing/0001395064-22-000040#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18.0,"shares_display":"18","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":342.0,"total_display":"342.00","total_whole":"342","shares_owned_after":7459286.0,"shares_owned_after_display":"7,459,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-14","filed_date":"2022-03-16","scope":"insider"},{"id":5412609,"accession":"0001395064-21-000248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001395064-21-000248","line_url":"/filing/0001395064-21-000248#line-3","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":null,"owner_name":"Takeda Pharmaceuticals U.S.A., Inc.; MILLENNIUM PHARMACEUTICALS INC; TAKEDA PHARMACEUTICAL CO LTD; Takeda Ventures, Inc.","owner_display_name":"Takeda Pharmaceuticals U.S.A., Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110338.0,"shares_display":"110,338","price_per_share":18.03,"price_display":"18.03","price_state":"stated","total_value":1989394.14,"total_display":"1,989,394.14","total_whole":"1,989,394","shares_owned_after":6120124.0,"shares_owned_after_display":"6,120,124","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-09","scope":"insider"},{"id":5412606,"accession":"0001395064-21-000248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000248","line_url":"/filing/0001395064-21-000248","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":null,"owner_name":"Takeda Pharmaceuticals U.S.A., Inc.; MILLENNIUM PHARMACEUTICALS INC; TAKEDA PHARMACEUTICAL CO LTD; Takeda Ventures, Inc.","owner_display_name":"Takeda Pharmaceuticals U.S.A., Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186935.0,"shares_display":"186,935","price_per_share":18.76307459812234,"price_display":"18.76","price_state":"stated","total_value":3507475.35,"total_display":"3,507,475.35","total_whole":"3,507,475","shares_owned_after":6288652.0,"shares_owned_after_display":"6,288,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-07","filed_date":"2021-12-09","scope":"insider","n_lines":2},{"id":5219601,"accession":"0001395064-21-000246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000246","line_url":"/filing/0001395064-21-000246#line-2","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":null,"owner_name":"MILLENNIUM PHARMACEUTICALS INC; Takeda Pharmaceuticals U.S.A., Inc.; Takeda Ventures, Inc.; TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"MILLENNIUM PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97692.0,"shares_display":"97,692","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":1763340.6,"total_display":"1,763,340.60","total_whole":"1,763,341","shares_owned_after":6417397.0,"shares_owned_after_display":"6,417,397","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":5219596,"accession":"0001395064-21-000246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000246","line_url":"/filing/0001395064-21-000246#line-1","is_derivative":false,"issuer_cik":"0001002637","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001002637","owner_cik":null,"owner_name":"MILLENNIUM PHARMACEUTICALS INC; Takeda Pharmaceuticals U.S.A., Inc.; Takeda Ventures, Inc.; TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"MILLENNIUM PHARMACEUTICALS INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12517.0,"shares_display":"12,517","price_per_share":18.47,"price_display":"18.47","price_state":"stated","total_value":231188.99,"total_display":"231,188.99","total_whole":"231,189","shares_owned_after":6515089.0,"shares_owned_after_display":"6,515,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-07","scope":"insider"},{"id":5021995,"accession":"0001395064-21-000231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000231","line_url":"/filing/0001395064-21-000231","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000001.0,"shares_display":"1,000,001","price_per_share":20.84999815000185,"price_display":"20.85","price_state":"stated","total_value":20850019.0,"total_display":"20,850,019.00","total_whole":"20,850,019","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider","n_lines":2},{"id":4250241,"accession":"0001395064-21-000153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000153","line_url":"/filing/0001395064-21-000153#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2609.0,"shares_display":"2,609","price_per_share":35.05,"price_display":"35.05","price_state":"stated","total_value":91445.45,"total_display":"91,445.45","total_whole":"91,445","shares_owned_after":871305.0,"shares_owned_after_display":"871,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-09","scope":"insider"},{"id":5388033,"accession":"0001395064-21-000148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000148","line_url":"/filing/0001395064-21-000148#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":3501.0,"total_display":"3,501.00","total_whole":"3,501","shares_owned_after":873914.0,"shares_owned_after_display":"873,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-06","scope":"insider"},{"id":5388031,"accession":"0001395064-21-000148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000148","line_url":"/filing/0001395064-21-000148#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8226.0,"shares_display":"8,226","price_per_share":35.16,"price_display":"35.16","price_state":"stated","total_value":289226.16,"total_display":"289,226.16","total_whole":"289,226","shares_owned_after":874014.0,"shares_owned_after_display":"874,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider"},{"id":5270442,"accession":"0001395064-21-000142","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001395064-21-000142","line_url":"/filing/0001395064-21-000142#line-3","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":35.08,"price_display":"35.08","price_state":"stated","total_value":12979.6,"total_display":"12,979.60","total_whole":"12,980","shares_owned_after":882240.0,"shares_owned_after_display":"882,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":5270439,"accession":"0001395064-21-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000142","line_url":"/filing/0001395064-21-000142","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24131.0,"shares_display":"24,131","price_per_share":35.491598358957354,"price_display":"35.49","price_state":"stated","total_value":856447.76,"total_display":"856,447.76","total_whole":"856,448","shares_owned_after":883860.0,"shares_owned_after_display":"883,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-29","scope":"insider","n_lines":2},{"id":4692638,"accession":"0001395064-21-000125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000125","line_url":"/filing/0001395064-21-000125#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10848.0,"shares_display":"10,848","price_per_share":35.14,"price_display":"35.14","price_state":"stated","total_value":381198.72,"total_display":"381,198.72","total_whole":"381,199","shares_owned_after":906741.0,"shares_owned_after_display":"906,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":4692633,"accession":"0001395064-21-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000125","line_url":"/filing/0001395064-21-000125#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":7000.0,"total_display":"7,000.00","total_whole":"7,000","shares_owned_after":917589.0,"shares_owned_after_display":"917,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-23","filed_date":"2021-06-25","scope":"insider"},{"id":4754222,"accession":"0001395064-21-000121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000121","line_url":"/filing/0001395064-21-000121#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":917789.0,"shares_owned_after_display":"917,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-23","scope":"insider"},{"id":4754218,"accession":"0001395064-21-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000121","line_url":"/filing/0001395064-21-000121#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9294.0,"shares_display":"9,294","price_per_share":35.31,"price_display":"35.31","price_state":"stated","total_value":328171.14,"total_display":"328,171.14","total_whole":"328,171","shares_owned_after":917889.0,"shares_owned_after_display":"917,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-23","scope":"insider"},{"id":5021974,"accession":"0001395064-21-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000119","line_url":"/filing/0001395064-21-000119#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5398.0,"shares_display":"5,398","price_per_share":35.13,"price_display":"35.13","price_state":"stated","total_value":189631.74,"total_display":"189,631.74","total_whole":"189,632","shares_owned_after":927183.0,"shares_owned_after_display":"927,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":5021970,"accession":"0001395064-21-000119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000119","line_url":"/filing/0001395064-21-000119#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3305.0,"shares_display":"3,305","price_per_share":35.08,"price_display":"35.08","price_state":"stated","total_value":115939.4,"total_display":"115,939.40","total_whole":"115,939","shares_owned_after":932581.0,"shares_owned_after_display":"932,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider"},{"id":5312859,"accession":"0001395064-21-000113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000113","line_url":"/filing/0001395064-21-000113#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2826.0,"shares_display":"2,826","price_per_share":35.06,"price_display":"35.06","price_state":"stated","total_value":99079.56,"total_display":"99,079.56","total_whole":"99,080","shares_owned_after":935886.0,"shares_owned_after_display":"935,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":5388029,"accession":"0001395064-21-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000111","line_url":"/filing/0001395064-21-000111#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2102.0,"shares_display":"2,102","price_per_share":35.14,"price_display":"35.14","price_state":"stated","total_value":73864.28,"total_display":"73,864.28","total_whole":"73,864","shares_owned_after":938712.0,"shares_owned_after_display":"938,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":5388027,"accession":"0001395064-21-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000111","line_url":"/filing/0001395064-21-000111#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":35.28,"price_display":"35.28","price_state":"stated","total_value":42018.48,"total_display":"42,018.48","total_whole":"42,018","shares_owned_after":940814.0,"shares_owned_after_display":"940,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-11","scope":"insider"},{"id":4500784,"accession":"0001395064-21-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000109","line_url":"/filing/0001395064-21-000109#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":942005.0,"shares_owned_after_display":"942,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-09","scope":"insider"},{"id":4500772,"accession":"0001395064-21-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000109","line_url":"/filing/0001395064-21-000109#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2264.0,"shares_display":"2,264","price_per_share":35.05,"price_display":"35.05","price_state":"stated","total_value":79353.2,"total_display":"79,353.20","total_whole":"79,353","shares_owned_after":942105.0,"shares_owned_after_display":"942,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":5219590,"accession":"0001395064-21-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000107","line_url":"/filing/0001395064-21-000107#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":35.18,"price_display":"35.18","price_state":"stated","total_value":151274.0,"total_display":"151,274.00","total_whole":"151,274","shares_owned_after":944369.0,"shares_owned_after_display":"944,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":5483206,"accession":"0001395064-21-000105","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001395064-21-000105","line_url":"/filing/0001395064-21-000105","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11211.0,"shares_display":"11,211","price_per_share":35.78000178396218,"price_display":"35.78","price_state":"stated","total_value":401129.6,"total_display":"401,129.60","total_whole":"401,130","shares_owned_after":952636.0,"shares_owned_after_display":"952,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider","n_lines":2},{"id":5483202,"accession":"0001395064-21-000105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001395064-21-000105","line_url":"/filing/0001395064-21-000105","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8905.0,"shares_display":"8,905","price_per_share":36.19366760247052,"price_display":"36.19","price_state":"stated","total_value":322304.61,"total_display":"322,304.61","total_whole":"322,305","shares_owned_after":964652.0,"shares_owned_after_display":"964,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-02","scope":"insider","n_lines":3},{"id":5021966,"accession":"0001395064-21-000103","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001395064-21-000103","line_url":"/filing/0001395064-21-000103","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8453.0,"shares_display":"8,453","price_per_share":37.14098071690524,"price_display":"37.14","price_state":"stated","total_value":313952.71,"total_display":"313,952.71","total_whole":"313,953","shares_owned_after":971064.0,"shares_owned_after_display":"971,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-05-28","scope":"insider","n_lines":2},{"id":5021950,"accession":"0001395064-21-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000103","line_url":"/filing/0001395064-21-000103","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12358.0,"shares_display":"12,358","price_per_share":36.63593866321411,"price_display":"36.64","price_state":"stated","total_value":452746.93,"total_display":"452,746.93","total_whole":"452,747","shares_owned_after":982127.0,"shares_owned_after_display":"982,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-28","scope":"insider","n_lines":2},{"id":4692628,"accession":"0001395064-21-000089","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001395064-21-000089","line_url":"/filing/0001395064-21-000089","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10947.0,"shares_display":"10,947","price_per_share":36.181525532109255,"price_display":"36.18","price_state":"stated","total_value":396079.16,"total_display":"396,079.16","total_whole":"396,079","shares_owned_after":990144.0,"shares_owned_after_display":"990,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-26","scope":"insider","n_lines":2},{"id":4692619,"accession":"0001395064-21-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000089","line_url":"/filing/0001395064-21-000089","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10594.0,"shares_display":"10,594","price_per_share":35.66260902397583,"price_display":"35.66","price_state":"stated","total_value":377809.68,"total_display":"377,809.68","total_whole":"377,810","shares_owned_after":1002226.0,"shares_owned_after_display":"1,002,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider","n_lines":2},{"id":4118754,"accession":"0001395064-21-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000087","line_url":"/filing/0001395064-21-000087#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11648.0,"shares_display":"11,648","price_per_share":35.74,"price_display":"35.74","price_state":"stated","total_value":416299.52,"total_display":"416,299.52","total_whole":"416,300","shares_owned_after":1011137.0,"shares_owned_after_display":"1,011,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-24","scope":"insider"},{"id":4118750,"accession":"0001395064-21-000087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000087","line_url":"/filing/0001395064-21-000087#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7098.0,"shares_display":"7,098","price_per_share":35.1,"price_display":"35.10","price_state":"stated","total_value":249139.8,"total_display":"249,139.80","total_whole":"249,140","shares_owned_after":1022785.0,"shares_owned_after_display":"1,022,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"},{"id":4299703,"accession":"0001395064-21-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000082","line_url":"/filing/0001395064-21-000082#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":3500.0,"total_display":"3,500.00","total_whole":"3,500","shares_owned_after":1029883.0,"shares_owned_after_display":"1,029,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":5483196,"accession":"0001395064-21-000078","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001395064-21-000078","line_url":"/filing/0001395064-21-000078#line-3","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":35.33,"price_display":"35.33","price_state":"stated","total_value":3533.0,"total_display":"3,533.00","total_whole":"3,533","shares_owned_after":1029983.0,"shares_owned_after_display":"1,029,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-14","scope":"insider"},{"id":5483194,"accession":"0001395064-21-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000078","line_url":"/filing/0001395064-21-000078","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11776.0,"shares_display":"11,776","price_per_share":35.44149031929348,"price_display":"35.44","price_state":"stated","total_value":417358.99,"total_display":"417,358.99","total_whole":"417,359","shares_owned_after":1030988.0,"shares_owned_after_display":"1,030,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-14","scope":"insider","n_lines":2},{"id":5513554,"accession":"0001395064-21-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000076","line_url":"/filing/0001395064-21-000076#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1011.0,"shares_display":"1,011","price_per_share":35.03,"price_display":"35.03","price_state":"stated","total_value":35415.33,"total_display":"35,415.33","total_whole":"35,415","shares_owned_after":1041859.0,"shares_owned_after_display":"1,041,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-11","scope":"insider"},{"id":5270433,"accession":"0001395064-21-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001395064-21-000060","line_url":"/filing/0001395064-21-000060#line-2","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":202.0,"shares_display":"202","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":7072.02,"total_display":"7,072.02","total_whole":"7,072","shares_owned_after":1042870.0,"shares_owned_after_display":"1,042,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-07","scope":"insider"},{"id":5270431,"accession":"0001395064-21-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001395064-21-000060","line_url":"/filing/0001395064-21-000060#line-1","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6936.0,"shares_display":"6,936","price_per_share":35.14,"price_display":"35.14","price_state":"stated","total_value":243731.04,"total_display":"243,731.04","total_whole":"243,731","shares_owned_after":1043072.0,"shares_owned_after_display":"1,043,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-07","scope":"insider"},{"id":5388025,"accession":"0001395064-21-000058","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001395064-21-000058","line_url":"/filing/0001395064-21-000058#line-7","is_derivative":false,"issuer_cik":"0001395064","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001395064","owner_cik":"0001395064","owner_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_display_name":"TAKEDA PHARMACEUTICAL CO LTD","owner_url":"/insider/0001395064","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11070.0,"shares_display":"11,070","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":392985.0,"total_display":"392,985.00","total_whole":"392,985","shares_owned_after":1058298.0,"shares_owned_after_display":"1,058,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-05","scope":"insider"}],"collapsed":true,"next_cursor":"2021-05-04|5388025","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001783183","name":"Phathom Pharmaceuticals, Inc.","url":"/issuer/0001783183","role":"Ten percent owner","n_filings":22,"first_seen":"2021-05-05","last_seen":"2024-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Ten percent owner","n_filings":2,"first_seen":"2021-12-07","last_seen":"2021-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001693415","name":"Translate Bio, Inc.","url":"/issuer/0001693415","role":"Ten percent owner","n_filings":3,"first_seen":"2020-06-03","last_seen":"2020-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001636651","name":"Ovid Therapeutics Inc.","url":"/issuer/0001636651","role":"Ten percent owner","n_filings":1,"first_seen":"2019-11-22","last_seen":"2019-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001679082","name":"Myovant Sciences Ltd.","url":"/issuer/0001679082","role":"Ten percent owner","n_filings":1,"first_seen":"2018-03-21","last_seen":"2018-03-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001395064","retrieved_at":"2026-08-26T15:36:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}